© 2022 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.
At our core is the commitment to our mission – to identify, develop and deliver life-changing therapies to people living with rare disease. This is what we do every day by working hard, supporting our team members and living our values – focused on patients, courage, community and collaboration. We strive to help our organization succeed by pursuing our vision – to become a leading biopharmaceutical company dedicated to the delivery of innovation and hope to patients in the global rare disease community.
Our number one priority will always be the patients we serve – they are why we come to work each day. Our Why is ingrained into our culture and is paramount to what we do every day or how we do it to achieve our mission of identifying, developing and delivering life-changing therapies to people living with rare disease. Many of our more than 250 team members worldwide have their own personal story that drives them to give rare patients a chance and provide hope. The #OurWhyRare campaign is a way for us to share these individual stories with the rare disease community and beyond.
At Travere Therapeutics, we speak many languages, hail from many continents, dress, talk, move, sense and work in different ways. We are more effective in our common purpose because of our individual differences and we celebrate the culture that we each contribute to.